Edition:
United Kingdom

China Biologic Products Holdings Inc (CBPO.OQ)

CBPO.OQ on NASDAQ Stock Exchange Global Select Market

79.37USD
22 May 2018
Change (% chg)

$0.50 (+0.63%)
Prev Close
$78.87
Open
$78.88
Day's High
$79.38
Day's Low
$78.88
Volume
2,786
Avg. Vol
77,524
52-wk High
$116.58
52-wk Low
$71.87

Chart for

About

China Biologic Products Holdings, Inc. is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment. China Biologic has a product... (more)

Overall

Beta: 1.44
Market Cap(Mil.): $2,712.35
Shares Outstanding(Mil.): 33.20
Dividend: --
Yield (%): --

Financials

  CBPO.OQ Industry Sector
P/E (TTM): -- 237.88 32.90
EPS (TTM): -- -- --
ROI: -- -7.38 12.74
ROE: -- -10.11 14.64

BRIEF-China Biologic Reports Q4 Adjusted Non-GAAP Earnings Per Share $0.90

* CHINA BIOLOGIC REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR 2017

28 Feb 2018

BRIEF-China Biologic To Build New Collection Station In Hainan Province

* CHINA BIOLOGIC TO BUILD NEW COLLECTION STATION IN HAINAN PROVINCE

14 Feb 2018

BRIEF-Marc Chan Reports 9.5 Percent Passive Stake In China Biologic Products Holdings As Of Dec 31, 2017

* MARC CHAN REPORTS 9.5 PERCENT PASSIVE STAKE IN CHINA BIOLOGIC PRODUCTS HOLDINGS INC AS OF DEC 31, 2017 - SEC FILING‍​ Source text - (http://bit.ly/2CffxTI) Further company coverage:

12 Feb 2018

BRIEF-China Biologic Receives Operating Permit For New Collection Facility In Ju County In Shandong Province

* CHINA BIOLOGIC RECEIVES OPERATING PERMIT FOR NEW COLLECTION FACILITY IN JU COUNTY IN SHANDONG PROVINCE Source text for Eikon: Further company coverage:

15 Dec 2017

Earnings vs. Estimates